experimentation

Blog entry

On February 8, 2012, Science magazine published research showing that bexarotene (TargretinĀ®), a drug approved for use in the US by the FDA for the very specific purpose of treating cutaneous T-cell lymphoma [CTCL] that can not be treated successfully with at least one other medication, that it can reduce brain amyloidal beta protein fragments in mice breed for Alzheimer's disease, increasing social skills and the sense of smell. http://www.sciencedaily.com/releases/2012/02/120209144005.htmMore »

Syndicate content